v. diagnóstico del asma en adultos - Instituto Guatemalteco de ...
v. diagnóstico del asma en adultos - Instituto Guatemalteco de ...
v. diagnóstico del asma en adultos - Instituto Guatemalteco de ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
14. Busse William, Jonathan Corr<strong>en</strong>, Bobby Qu<strong>en</strong>tin Lanier, Margaret McAlary,<br />
Angel Fowler-Taylor, Giovanni Della Cioppa, Andre Van As, and Niroo<br />
Gupta. Omalizumab, anti-IgE recombinant humanized monoclonal<br />
antibody, for the treatm<strong>en</strong>t of severe allergic asthma. Allergy, rhinitis, other<br />
respiratory diseases. March 2, 2001; revised June 12, 2001. Copyright 2001<br />
by Mosby, Inc. USA.<br />
15. Corr<strong>en</strong> Jonathan, Thomas Casale, Yamo D<strong>en</strong>iz and Mark Ashby.<br />
Omalizumab a recombinant humanized anti-IgE antibody reduces asthmarelated<br />
emerg<strong>en</strong>cy room visits and hospitalizations in pati<strong>en</strong>ts with allergic<br />
asthma. Brief communication. 2003 Mosby, Inc. USA.<br />
16. D<strong>en</strong>nis Nowak, Managem<strong>en</strong>t of asthma with anti-immunoglobulin E: A<br />
review of clinical trials of omalizumab. Respiratory Medicine (2006) 100,<br />
1907-1917. Published by Elsevier Ltd. USA.<br />
17. Humbert M, Beasley R, Ayres J, Slavin R, Hebert J, Bousquet J, y cols.<br />
B<strong>en</strong>efits of Omalizumab as add-on therapy in pati<strong>en</strong>ts with severe persist<strong>en</strong>t<br />
asthma who is ina<strong>de</strong>quately controlled <strong>de</strong>spite best available therapy.<br />
September 2004.<br />
18. Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH. Anti-IgE for<br />
chronic asthma in adults and childr<strong>en</strong> (review) The Cochrane Collaboration<br />
Library 2007.<br />
19. Directrices GINA <strong>de</strong> 2002. Global strategy for Asthma Managem<strong>en</strong>t and<br />
Prev<strong>en</strong>tion NH LBI/WHO Workshop. Workshop Report, 2003.<br />
20. Directrices GINA <strong>de</strong> 2003. Global strategy for Asthma Managem<strong>en</strong>t and<br />
Prev<strong>en</strong>tion NH LBI/WHO Workshop. Workshop Report, 2003.<br />
21. Extracts from “Clinical Evid<strong>en</strong>ce”. Chronic Asthma Clinical review. Extracts<br />
from “Clinical Evid<strong>en</strong>ce” October 2001, BMJ; 323, 976-979.<br />
22. Gómez Lozano, Parra Madrid, Pulido Plazuelo, Rada Casas, V<strong>en</strong>tura<br />
López. Asma Bronquial. Boletín Fármaco terapéutico <strong>de</strong> Castilla La<br />
Mancha. Sescam. Vol III – No.-5 año 2002 Guadalajara, Puertollano<br />
Talavera <strong>de</strong> la Reina y Toledo. España.<br />
23. Gui<strong><strong>de</strong>l</strong>ines for the Prev<strong>en</strong>tion and Treatm<strong>en</strong>t of Influ<strong>en</strong>za and the Común<br />
Cold. 2002, American Lunf Association.<br />
24. Guía <strong>de</strong> Práctica Clínica <strong>de</strong> Asma. España 2,006.<br />
25. H. Pauwels, KN Desager, WL Cret<strong>en</strong>, J. Van Der Vek<strong>en</strong>, HP Van Bever.<br />
Study of the bronchodilating effect of three doses of nebulized oxitropium<br />
bromi<strong>de</strong> in asthmatic preschool childr<strong>en</strong> using the torced oscillation<br />
technique. J European Journal of Pediatrics, 03/25/1997, Vol 156(4), p329-<br />
333.<br />
42
Change language